#GDR 1 of loads...
Key points:
Unique collaboration (Aug 2020) with Beckman Coulter, multi £b company with global reach and substantial financial capability possessing huge leverage in the market place
Well developed sales & support infrastructure across UK, Europe & the USA
Key points:
Unique collaboration (Aug 2020) with Beckman Coulter, multi £b company with global reach and substantial financial capability possessing huge leverage in the market place

Well developed sales & support infrastructure across UK, Europe & the USA
#GDR
Synergistic product portfolio specifically the RNA extraction chemistries and Robotic solutions to drive efficiency and volume in testing labs. Genedrive’s is an automation-friendly PCR test
Synergistic product portfolio specifically the RNA extraction chemistries and Robotic solutions to drive efficiency and volume in testing labs. Genedrive’s is an automation-friendly PCR test

#GDR
Deployment:
Purchasing = Full solution for end-user.
Clinical = Validates components for end-user
Customer perspective – Scientific and tech capability to support end-to-end solutions
•Huge testing shortfall in the US (more efficient methods/systems demanded)
Deployment:
Purchasing = Full solution for end-user.
Clinical = Validates components for end-user
Customer perspective – Scientific and tech capability to support end-to-end solutions

•Huge testing shortfall in the US (more efficient methods/systems demanded)

#GDR
USA Drivers:
•B+C well established US company
•Labs paid high reimbursement rates for doing a test - $120
•Higher rates remove pricing pressure on suppliers
•US is a private healthcare market= Labs and Doctors can move faster & make own decisions (no lengthy tenders)
USA Drivers:
•B+C well established US company
•Labs paid high reimbursement rates for doing a test - $120
•Higher rates remove pricing pressure on suppliers
•US is a private healthcare market= Labs and Doctors can move faster & make own decisions (no lengthy tenders)

#GDR
Financial Deals:
•Material and significant
•Fully aligned with B&C on the financials
Supply chain:
Tests are designed to target multiple components of a virus to look at different regions and detect developments
Financial Deals:
•Material and significant
•Fully aligned with B&C on the financials
Supply chain:
Tests are designed to target multiple components of a virus to look at different regions and detect developments

#GDR
Potential:
Automated Instalation. Biomek=1000 tests 8 hours @ $120 per test for the lab. Then consider multiple machines & extra shifts per site, eg. 2 machines x 8 hours=2000 tests= c$240,000, add an extra shift on those 2 machines & you get c$480,000 in a 16 hour period
Potential:
Automated Instalation. Biomek=1000 tests 8 hours @ $120 per test for the lab. Then consider multiple machines & extra shifts per site, eg. 2 machines x 8 hours=2000 tests= c$240,000, add an extra shift on those 2 machines & you get c$480,000 in a 16 hour period
